Rumored Buzz on cgmp compliance
No. 21 CFR 211.113(a) calls for correct written treatments to generally be proven and followed all through manufacturing to forestall objectionable microorganisms in drug products not needed to be sterile. Also, the 2nd paragraph of USP Typical Chapter Antimicrobial Usefulness Testing reads: Antimicrobial preservatives really should not be